Gene therapy with p14/tbid induces selective and synergistic apoptosis in mutant ras and mutant p53 cancer cells in vitro and in vivo

HIGHLIGHTS

• who: Robert L. Fine et al. from the Herbert Irving Comprehensive Cancer Center, NYPH-Columbia University Medical Center, New York, NY, USA have published the research work: Gene Therapy with p14/tBID Induces Selective and Synergistic Apoptosis in Mutant Ras and Mutant p53 Cancer Cells In Vitro and In Vivo, in the Journal: Biomedicines 2022, 10, x FOR PEER REVIEW construct of /2022/
• how: All experiments were conducted in compliance with protocols approved by the Institutional Animal Care and Use Committee of Columbia University Medical Center (CUMC). The mice were a mixed 129/SvJae/C57Bl . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.